View profile

Weekly newsletter of Ahmed Negida - Issue #14

Ahmed Negida
Ahmed Negida
Hi Friends,
I’m not a big fan of football (soccer) so do not expect me to comment on Egypt’s matches; which I have not watched :D

From the Neurosurgical Operation Room
Tuesday 27/07/2021
Tuesday 27/07/2021
New things that I found on the internet
UpSurgeon is a new technology simulating real brain models enabling neurosurgeons and neurosurgical trainees to practice operations on brain-like models with 3D visualization.
UpSurgeOn | Craniotomy on BrainBox
UpSurgeOn | Craniotomy on BrainBox
What I'm reading read this week
This week, I did not read anything new … I was busy with some work for the Congress of Neurological Surgeons (CNS, late abstract submissions).
Best YouTube video I watched this week
The concept of time travelling has gone viral on social media owing to some TikTok videos by a few people claiming to be in 2027. I watched the video below and I realized that everything is possible through graphic and video editing techniques.
Javier in 2027 How Did He Remove All The People Unicosobreviviente
Javier in 2027 How Did He Remove All The People Unicosobreviviente
The course I'm taking this week
This weekend, I’m studying the course entitled: “ArcGIS Insights Basics - Data Analysis and Visualization” by Micah, on Skillshare.
The course I'm teaching this weekend
Negida Clinical Research Training for Summer 2021 starts next Thursday (5th of August 2021). For more information about the training, you can visit the link below.
Summer School of Clinical Research 2021
[END] ... Thank you very much!
Did you enjoy this issue? Yes No
Ahmed Negida
Ahmed Negida @NegidaMD

I’m Ahmed, a medical doctor from Egypt, a Ph.D. candidate in the UK, and a Global Neurosurgery Fellow at Harvard Medical School.

Every week I send an email newsletter with some ideas, quotes, life lessons, and new interesting things I found on the internet that week.

In order to unsubscribe, click here.
If you were forwarded this newsletter and you like it, you can subscribe here.
Created with Revue by Twitter.